|
|
|
Insider
Information: |
Arbuckle Stuart A |
Relationship: |
Director |
City: |
Cambridge, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
62,795 |
|
Indirect Shares
|
140 |
|
|
Direct
Value |
$21,926,350 |
|
|
Indirect Value
|
$61,758 |
|
|
Total
Shares |
62,935 |
|
|
Total
Value |
$21,988,108 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-17 |
4 |
D |
$241.50 |
$602,784 |
D/D |
(2,496) |
44,839 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-18 |
4 |
AS |
$242.08 |
$761,842 |
D/D |
(3,128) |
41,711 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-24 |
4 |
D |
$239.23 |
$693,289 |
D/D |
(2,898) |
38,813 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-25 |
4 |
AS |
$229.78 |
$849,418 |
D/D |
(3,634) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-05-04 |
4 |
OE |
$86.52 |
$134,366 |
D/D |
1,553 |
36,732 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-05-04 |
4 |
AS |
$259.36 |
$404,957 |
D/D |
(1,553) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-05-15 |
4 |
AS |
$276.35 |
$32,089 |
D/D |
(113) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-07-07 |
4 |
AS |
$300.00 |
$835,800 |
D/D |
(2,786) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-07-07 |
4 |
OE |
$155.57 |
$483,403 |
D/D |
2,786 |
37,965 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-08-03 |
4 |
OE |
$86.52 |
$134,366 |
D/D |
1,553 |
36,732 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-08-03 |
4 |
AS |
$276.40 |
$432,337 |
D/D |
(1,553) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-11-03 |
4 |
OE |
$86.52 |
$134,366 |
D/D |
1,553 |
36,732 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-11-03 |
4 |
AS |
$210.56 |
$329,115 |
D/D |
(1,553) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-11-16 |
4 |
AS |
$222.47 |
$1,565 |
D/D |
(7) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-03 |
4 |
AS |
$211.22 |
$332,146 |
D/D |
(1,554) |
69,957 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
34,778 |
69,957 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-03 |
4 |
OE |
$86.52 |
$134,452 |
D/D |
1,554 |
71,511 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-10 |
4 |
D |
$214.16 |
$664,110 |
D/D |
(3,101) |
66,856 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-11 |
4 |
AS |
$210.39 |
$1,085,593 |
D/D |
(5,156) |
61,700 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-17 |
4 |
D |
$211.75 |
$1,321,320 |
D/D |
(6,240) |
55,460 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-18 |
4 |
AS |
$210.05 |
$1,657,481 |
D/D |
(7,825) |
47,635 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-24 |
4 |
D |
$217.57 |
$630,518 |
D/D |
(2,898) |
44,737 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-25 |
4 |
AS |
$211.39 |
$775,989 |
D/D |
(3,634) |
41,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Comm & Ops Officer |
|
2021-05-17 |
4 |
AS |
$215.33 |
$23,589 |
D/D |
(109) |
41,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2021-11-15 |
4 |
AS |
$186.99 |
$562 |
D/D |
(3) |
41,103 |
0 |
% |
|
192 Records found
|
|
Page 6 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|